Invention Grant
- Patent Title: ERK inhibitors for use in treating spinal muscular atrophy
-
Application No.: US14119906Application Date: 2012-05-24
-
Publication No.: US09833439B2Publication Date: 2017-12-05
- Inventor: Frédéric Charbonnier , Olivier Biondi
- Applicant: Frédéric Charbonnier , Olivier Biondi
- Applicant Address: FR Paris FR Paris
- Assignee: UNIVERSITE PARIS DESCARTES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: UNIVERSITE PARIS DESCARTES,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: FR Paris FR Paris
- Agency: Seyfarth Shaw LLP
- International Application: PCT/EP2012/059685 WO 20120524
- International Announcement: WO2012/160130 WO 20121129
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K48/00 ; A61K31/4184 ; A61K31/136 ; A61K31/16 ; A61K31/166 ; A61K31/352 ; A61K31/4412 ; A61K31/713 ; A61K31/7088
Abstract:
The present invention relates to a method for treating spinal muscular atrophy and other related neuromuscular disorders in a subject in need thereof, said method comprising administering a therapeutically effective amount of an ERK inhibitor, such as Selumetinib to said subject.
Public/Granted literature
- US20140113956A1 ERK INHIBITORS FOR USE IN TREATING SPINAL MUSCULAR ATROPHY Public/Granted day:2014-04-24
Information query
IPC分类:
